Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.00 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This presentation will focus on medications commonly prescribed for dermatology conditions such as atopic dermatitis, psoriasis, skin infections and infestations, acne, molluscum and warts. Learners will gain a knowledge of common treatments and applicable clinical judgement skills to choose optimal medication treatment options for our patients.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide the participant with up-to-date information pharmacological management of common respiratory illnesses in children.
  • Primary Care
  • Acute Care
  • Infectious Disease
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Current information from CDC will be reviewed. Most current information about vaccine safety will also be covered.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide an up‐to‐date information on current recommendations for use of GI drugs in the pharmacological management of common GI pathologies in children.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This module will introduce nutraceuticals and review common pediatric uses for nutraceuticals.
  • Primary Care
  • Acute Care
  • Infectious Disease
  • Pharmacology CE
  • Contact hours
$25.00
1.25 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12 for NAPNAP Members. For non- members, this continuing education activity rate is $25. This presentation will discuss prescribing for pediatric patients in light of spotlights on inappropriate antibiotic prescribing. A rapid review of current guidelines for treating pediatric infectious diseases will frame a discussion on how to incorporate guidelines into daily practice. Local and national resistance patterns will be discussed, as well as adverse effects of antibiotics including rising resistance and C. difficile rates.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide the participant with up-to-date information pharmacological management of common respiratory illnesses in children.
  • Primary Care
  • FREE for Members
  • Pharmacology CE
  • Psychopharmacology CE
  • Controlled Substances CE
  • Contact hours
$10.00
0.5 contact hour of which 0.5 contain pharmacology content and 0.5 controlled substances.This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Urine drug screening (UDS) is a laboratory test frequently used to screen for drugs of abuse, monitor for medication compliance, evaluate for suspected drug intoxication or overdose, and in office-based pain contracts (Kale, 2019; Standridge, Adams, & Zotos, 2010). In children and adolescents,UDS may be used to prevent substance use, evaluate for suspected drug use or intoxication, or as part of substance abuse treatment (Levy & Siqueira, 2014). When using UDS as a tool to make clinical decisions about high-risk medications, it is important to understand the differences between UDS testing modalities, common causes of falsepositive or false-negative results, and the detection window of specific medications. There are two commonly used types of UDS available: immunoassay and gas chromatography/ mass spectrometry (GC-MS; Kale, 2019).
  • Primary Care
  • Acute Care
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Controlled Substances CE
$90.00
5.25 NAPNAP Contact Hours, 3.75 Pharmacology, 3.75 Psychopharmacology and 0.25 is Controlled substance. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $42 for NAPNAP Members. For non- members, this continuing education activity rate is $90. The bundle will provide a closer look on Neuropsychiatric Medications and The Application in Pediatric Practice , Psychotropic Medications, Effects of Cannabis on Children and Adolescents, Anxiety and Depression through the Waves of COVID-19, and Racial/Ethnic Disparities in Mental Health.
  • Primary Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Penicillin allergy, the most commonly reported allergy in a pediatric patient, is associated with increases in cost of care, hospitalization and morbidity, as well as contributing to antibiotic resistance. However, 95% of patients labeled with a penicillin allergy do not have a true allergy. The Centers for Disease Control & Prevention has identified improper use of antibiotics to be an important factor that must be addressed for both patient safety and public health. This presentation will identify high-risk symptoms of allergy, differentiate between adverse reactions, IgE-mediated allergic reaction and delayed T-cell reactions, as well as discuss appropriate testing for penicillin allergy. Additionally, the presenter will address alternative antibiotics that can be used until a formal allergy evaluation can be completed.

Pages